Ken Araki has a responsibility to initiate and manage global corporate-wide strategic projects to support Takeda’s Senior Management team including President & CEO at the company. His team is also heavily involved in building up company’s strategic direction based o…more ›

Mr. Casey is responsible for Quintiles’ corporate development and partnering functions for the Asia, Australia and Africa regions. These responsibilities include deal structuring, negotiation and due diligence. Mr. Casey has been with Quintiles for 17 years. He has hel…more ›

Emma leads the mainland China corporate practice of Clifford Chance and the healthcare and life sciences group in Asia. She is bilingual in Mandarin and English and has spent over 15 years in Asia advising businesses on their investments in China. In addition to advisin…more ›

Sinclair has almost two decades of international experience in evaluating early-stage biotechnology companies. He is Founder and Managing Partner of MASA Life Science Ventures LP, a trans-Pacific venture fund investing in private, high-growth biotechnology and life sci…more ›

Helmut Haning studied chemistry at the University of Mainz, Germany and the Polymer Science and Engineering Department, Massachusetts, USA. After receiving his MS in the field of stereoselective synthesis, he did his PhD in the Goup of Prof. M. T. Reetz at the Max Planc…more ›

Carrie has led the Life Sciences practice in CM Capital Investments for over 10 years, investing and been the inventor of a number of patents and has been involved in the complete product lifecycle, including medical research in London and developing, licensing and mar…more ›

Ling is a partner in Clifford Chance's Hong Kong office, where she heads the Intellectual Property Group in Asia and acts as Co-Head of Clifford Chance’s Litigation and Dispute Resolution Practice in China. Ling is admitted in both Hong Kong and England & Wales.…more ›

Peter Homberg is partner of the law firm Raupach & Wollert-Elmendorff and head of its Frankfurt office and of Raupach’s Life Sciences Practice Group. He is specialized in R&D and cooperation agreements, cross-border IP licensing and IP strategies as well as in M…more ›

Hu Hsing has been an advisor to TVM Capital since late 2004 and joined TVM Capital as Venture Partner for life sciences in 2007. She entered the life sciences industry in 2000 when she was a Senior Vice President at Vertex Management, where she co-led the Global Biotech…more ›

With 25 years of diverse industry background in biotechnology including 10 years of executive management experience, Nazlee brings in strong acumen in both the technical and business aspects of biotechnology to BiotechCorp. Recognised for his wide industrial leadership,…more ›

Deanna Petersen joined Shire in 2009 as Vice President of Business Development for Shire Human Genetic Therapies (HGT). Deanna is a broadly skilled senior executive with 15 years of leadership experience in strategic planning and global business development. Deanna is…more ›

Kiran Mazumdar-Shaw's pioneering efforts in biotechnology have drawn global recognition both for Indian Industry and Biocon. Her unique vision has steered Biocon's transition from an industrial enzymes company to an integrated biopharmaceutical company with stra…more ›

Helmut leads the head of Global Innovation Sourcing at Bayer where he handles activities such as early licensing, academic partnerships and alliance management. He will be sharing on the paradigm shift from traditional R & D towards new emerging

Currently Mr. Rindell is Senior Director of Corporate Development for Amylin Pharmaceuticals, Inc., a position he has held since 2005. He has led and participated in a number of key global transactions in both diabetes and obesity, including transactions with Shionogi P…more ›

Alfred Scheidegger is the founder and CEO of Nextech Venture, Ltd., a globally active investment management firm based in Zurich, Switzerland. Nextech Venture manages and advises three investment funds of USD 166 million with a focus on oncology. Prior to founding Nexte…more ›

Ravi studied in the UK obtaining B.Sc. in Pharmacology, Ph.D. and MBA. He spent several years in Research (London University, Zurich University Hospitals, Ciba Geigy Basel), Clinical Development (SmithKline Beecham) and Sales & Marketing (Novartis). In 1999 Ravi m…more ›